ASND

Ascendis Pharma A/S is a biopharmaceutical innovator based in Hellerup, Denmark, dedicated to creating transformative therapies for significant unmet medical needs in various therapeutic areas, particularly rare diseases and endocrine disorders. Leveraging its proprietary TransCon™ technology platform, the company is actively advancing a promising pipeline of product candidates through rigorous clinical trials. Ascendis is focused not only on developing groundbreaking treatments but also on establishing a sustainable business model that prioritizes patient health and supports long-term growth initiatives.